Shares in Swiss pharma group rally after analyst discovers data on immunotherapy medicine on website
The late-stage trial involves 534 patients with advanced non-small cell lung cancer, a prevalent type of the disease.
Patents on some of the biggest immunoncology drugs are set to expire before 2030, however, and drugmakers are searching for a future generation of more effective drugs to generate new sources of revenue. Shares in large pharma companies that are also developing anti-TIGITs rose. GSK was up 1.7 per cent in midday trading in London, while Merck and Gilead added 1.2 per cent and 0.9 per cent, respectively, in pre-market trading in New York.
España Últimas Noticias, España Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Irish drug developer signs licensing deal for autoimmune therapiesInflection Biosciences chief Darren Cunningham will become CEO of Swiss-based Mysthera Therapeutics
Leer más »
Ukrainian driver shares his sniper secretsNationalist paramilitary group member reflects on his own life, on history and on killing Russians
Leer más »
Hair expert shares seven common mistakes we all make that are damaging our locksMuch like skincare, haircare requires attention to our individual needs and sometimes what you think is the right thing could be actually quite damaging to your tresses
Leer más »
European shares recover from six-week low as investors’ eyes turn to crucial US Fed meetingMeanwhile, as China’s central bank surprised analysists and delivered a smaller than expected cut to lending rates, Asian stocks tumbled, and these policy signals from China also weighed on sentiment in other global markets.
Leer más »
Tommy Bowe shares rare snaps with wife Lucy and their two kidsThe former rugby player has returned to the Virgin Media morning show after enjoying some time off with his wife Lucy and their two children Emma and Jamie in Portugal
Leer más »
Vintage lover Pearl Lowe shares her tips for finding your own second-hand treasuresFrom where to look to how to spot a piece worth snapping up, the vintage maven has lots of sage advice.
Leer más »